Biopharmaceutical excipients are substances, other than the active pharmaceutical ingredient (应用程序编程接口), that are added to a biopharmaceutical drug product to enhance its stability, 安全, and efficacy. These substances can interact with the API or with other excipients, influencing the physical and chemical properties of the formulation, the drug delivery system, and the bioavailability of the drug. The global biopharmaceutical excipients market is likely to register a CAGR of over 7.81% 随着美元的增量增长 1.3 预测期内 10 亿 2023-2029.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global biopharmaceutical excipients market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the excipient, 生物制剂, scale of operation, 最终用户, 和地区. The global market for biopharmaceutical excipients can be segmented by excipient: bulking agents, solubilizers & 表面活性剂, buffering & tonicity agents, 其他的. The bulking agents segment held the largest share of the global biopharmaceutical excipients market in 2022 预计在预测期内将持有其份额. Biopharmaceutical excipients market is further segmented by biologics: 单克隆抗体, 疫苗, 其他的. 全球范围, the monoclonal antibodies segment made up the largest share of the biopharmaceutical excipients market. Based on scale of operation, the biopharmaceutical excipients market is segmented into: 商业的, 研究. The commercial segment was the largest contributor to the global biopharmaceutical excipients market in 2022. 基于最终用户, the biopharmaceutical excipients market also can be divided into: pharma & biotech companies, cmos & cdmos, 学术的 & 研究机构, 其他的. The pharma & biotech companies segment is estimated to account for the largest share of the global biopharmaceutical excipients market. Biopharmaceutical excipients market by region is categorized into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

市场细分
By excipient: bulking agents, solubilizers & 表面活性剂, buffering & tonicity agents, 其他的
By biologics: 单克隆抗体, 疫苗, 其他的
By scale of operation: 商业的, 研究
按最终用户: pharma & biotech companies, cmos & cdmos, 学术的 & 研究机构, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report also provides a detailed analysis of several leading biopharmaceutical excipients market vendors that include Merck KGaA, 阿凡特公司, 巴斯夫公司, 赢创工业股份公司, 罗盖特兄弟公司, 相关的英国食品PLC, Ashland Global Holdings Inc., 科莱恩公司, Fuji Chemical Industry Co., 有限公司, 陶氏公司, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global biopharmaceutical excipients market.
• To classify and forecast the global biopharmaceutical excipients market based on excipient, 生物制剂, scale of operation, 最终用户, 地区.
• To identify drivers and challenges for the global biopharmaceutical excipients market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global biopharmaceutical excipients market.
• To identify and analyze the profile of leading players operating in the global biopharmaceutical excipients market.

为什么选择这份报告
• Gain a reliable outlook of the global biopharmaceutical excipients market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.